Metabolic Disease/Endocrinology

Disorders of the endocrine system and metabolic diseases are associated with complex clinical trials, due to the interconnected nature of the HPA axis (hypothalamus, pituitary, adrenal) and the liver, pancreas, and gallbladder.


ARG’s expertise in this therapeutic area includes drug discovery for antidiabetic efficacy studies, intradialytic hypotension, and biomarker services.


Previous trials experience includes but is not limited to Type I/II and Pediatric Diabetes, as well as renal disease.